BridgeMD
Compares treatment options for Dystonic Tremor
Official title PSA Versus STN DBS for DT
ClinicalTrials.gov ID: NCT06752434
What this study is testing
- What it's testing
- The aim of this study is to compare the effectiveness of the deep brain stimulation in the posterior subthalamic area (PSA) versus the subthalamic nucleus (STN) for the treatment of dystonic tremor (DT) in a randomized, double-blinded, cross-over manner.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- Diagnosed with dystonic tremor based on the MDS 2018 consensus
- Duration of DT symptoms: ≥3 years of motor symptoms
- If the patient is taking tremor medications, the medications should be stable for 28 days prior to informed consent
- Good compliance and written informed consent
You likely can't join if
- Any intracranial abnormalities that would prevent DBS surgery
- Any significant mental illness that might affect the subject's ability to comply with the study protocol requirements (e.g., bipolar disorder...
- Severe cognitive impairment, MOCA score \<24
- Any current substance or alcohol abuse according to DSM-V criteria
- Any history of recurrent or unprovoked epileptic seizures; any prior movement disorder treatment involving intracranial surgery or device...
- Any terminal illness with a life expectancy of \<1 year
The study team makes the final eligibility decision.
Where it's taking place
- Shanghai, Shanghai Municipality, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shanghai, Shanghai Municipality, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.